NuGen Medical Devices Inc. announced the official launch on Shopify of its diabetic's lifestyle subscription business at offering diabetics the ability to purchase revolutionary needle-free InsuJet?? device and consumables online, direct to consumer with a subscription-based model. is a consumer-centric platform custom-built for NuGen's diabetic subscription-based lifestyle business that fully integrates e-commerce functionality powered by Shopify for a secure and efficient shopping experience.

Using advanced analytics and tracking capabilities to monitor user behaviour and optimize conversion rates using Triple Whale and Heat Maps, the website is designed to be highly scalable, ready to accommodate InsuJet's?? growth and expansion into multiple markets. With multi-language support, ensures accessibility and appeals to diverse demographics in regions where InsuJet??

is poised to expand. The website caters to global traffic and adheres to each geographical location's laws, languages, and cultural nuances where the product is registered as a medical device and can be legally sold. The Company has invested in search engine optimization and content marketing to build out the website's capabilities in handling increased traffic, thereby improving organic growth.

During beta testing, the website successfully handled a 30% month-to-month increase in organic traffic caused by a viral video on TikTok that garnered over 730,000 views within 24 hours. The website's capabilities have been stress-tested to ensure it is prepared to handle the scale of global traffic, setting up a sturdy platform for future paid traffic campaigns. serves as a central hub for InsuJet's??

revolutionary needle-free diabetes management solution. By supporting both B2C and B2B channels, the website is expected to open avenues for widespread adoption and significant market penetration. The necessity of the product, combined with the convenience of the subscription model, will position InsuJet??

for exponential growth and scalability. With the diabetic lifestyle sector continually expanding, InsuJet?? stands at the threshold of capturing and increasing its market share.

NuGen expects to position itself as the go-to Diabetic lifestyle subscription business, with the new website acting as a vehicle to turn visitors into customers. How InsuJet.com Generates Revenue: The seamless integration of subscriptions and individual purchases provides a steady and predictable revenue stream. Strategic placement of call-to-action buttons and promotional content, optimized for conversion.

Built with foresight to escalate sales and grow the business across multiple languages and geographical locations. Poised to introduce paid traffic campaigns to accelerate recurring subscription revenue growth, alongside optimizing user journeys for a more custom experience catering to customers' needs. Offered as both a single unit and a subscription offering, various pricing and examples can be found at .

Subscription Model Expanded: Improvement of Business Channels - The Product as a Necessity and Scaling Potential. InsuJet's?? needle-free diabetes management solution is not just a product; it's a vital tool for improving quality of life.

The adoption of the subscription model is a strategic move, ensuring that users have continuous access to this essential product. This recurring revenue model, supported by a robust digital platform, lays the groundwork for InsuJet?? to scale to new heights, as the Company aims to establish a substantial market presence and increase its valuation.

The website educates customers on a novel solution for administering insulin, portraying trust and ease of use, a crucial step towards scaling the business. Significant preparations like customization for different geographical locations and languages, and robust tracking frameworks, reflect the proactive steps taken towards scaling in 2024. To this end, the new website enhances the direct-to-consumer channel by providing a seamless shopping experience, extensive product information, and personalized recommendations.